All lobbying filings

THE INGRAM GROUP LLC

THE INGRAM GROUP LLC filed a Q1 termination report for LYNCH REGENERATIVE MEDICINE, LLC on April 17, 2026, reporting $10,000 in lobbying income.

Lobbying for LYNCH REGENERATIVE MEDICINE, LLC · biotech company

All filings by THE INGRAM GROUP LLC · Everything LYNCH REGENERATIVE MEDICINE, LLC has reported

Filing · LD-2 quarterly report Q1 termination

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

Tennessee

Representation ended

Jan 31, 2026

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Issues related to Local Coverage Determinations (LCDs) implementation. Issues related to the Finalized CY 2026 Medicare Physician Fee Schedule (PFS) and Hospital Outpatient Prospective Payment System (OPPS).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.